Caricamento...
An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth
BACKGROUND: Recent reports of the remarkable therapeutic efficacy of 225Ac-labeled PSMA-617 for therapy of metastatic castration-resistant prostate cancer have under-lined the clinical potential of targeted alpha therapy. OBJECTIVE AND CONCLUSION: This review describes methods for the production of...
Salvato in:
| Pubblicato in: | Curr Radiopharm |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Bentham Science Publishers
2018
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6237921/ https://ncbi.nlm.nih.gov/pubmed/29732998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1874471011666180502104524 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|